Fulgent Genetics, Inc. (FLGT) earnings

FLGT earnings moved a median of -0.17% by the close. Quarterly and annual FLGT reports and results, each read against the price at its own news timestamp. Back to the FLGT overview →

30 measured FLGT earnings events.

Where these FLGT earnings landedvs 30 measured FLGT earnings reactions
FLGT earningsMiddle 50% · -3.46% to +9.57%Zero: 0.00%Median: -0.17%Median -0.17%-15.00%0+15.00%
Middle 50% of FLGT earnings reactions-3.46% to +9.57%
Median reaction (to close)-0.17%
Measured reactions30
Point-in-time · zero look-ahead

Half of the 30 FLGT earnings events with a measured close landed between -3.46% and +9.57%; 47% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q Fulgent Genetics, Inc. For: Jun 30SEC filing · Form 10-Q+1.42%-3.83%
Fulgent Reports Second Quarter 2026 Financial ResultsPress release+1.42%-3.83%
Fulgent to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026Press release-0.33%-2.00%
Form 10-Q Fulgent Genetics, Inc. For: Mar 31SEC filing · Form 10-Q-0.55%-3.09%
Fulgent Reports First Quarter 2026 Financial ResultsPress release+6.77%+0.64%
Fulgent to Announce First Quarter 2026 Financial Results on Friday, May 1, 2026Press release+0.46%-0.25%
Form 10-K Fulgent Genetics, Inc. For: Dec 31SEC filing · Form 10-K-3.70%-17.71%
Form 10-Q Fulgent Genetics, Inc. For: Sep 30SEC filing · Form 10-Q+13.31%+9.65%
Fulgent Reports Third Quarter 2025 Financial ResultsPress release+13.31%+9.65%
Fulgent to Announce Third Quarter 2025 Financial Results on Friday, November 7, 2025Press release+0.83%-0.57%
Form 10-Q Fulgent Genetics, Inc. For: Jun 30SEC filing · Form 10-Q-3.14%-3.74%
Fulgent Reports Second Quarter 2025 Financial ResultsPress release-3.14%-3.74%
Fulgent to Announce Second Quarter 2025 Financial Results on Friday, August 1, 2025Press release-0.34%-0.82%
Form 10-Q Fulgent Genetics, Inc. For: Mar 31SEC filing · Form 10-Q+6.35%+12.86%
Fulgent Reports First Quarter 2025 Financial ResultsPress release+6.35%+12.86%
Fulgent to Announce First Quarter 2025 Financial Results on Friday, May 2, 2025Press release-0.34%+9.32%
Form 10-K Fulgent Genetics, Inc. For: Dec 31SEC filing · Form 10-K-1.81%-3.19%
Form 10-Q Fulgent Genetics, Inc. For: Sep 30SEC filing · Form 10-Q-5.40%-11.08%
Fulgent Reports Third Quarter 2024 Financial ResultsPress release-5.40%-11.08%
Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024Press release-0.10%+0.36%
Form 10-Q Fulgent Genetics, Inc. For: Jun 30SEC filing · Form 10-Q-0.22%+12.38%
Fulgent Reports Second Quarter 2024 Financial ResultsPress release-0.22%+12.38%
Fulgent to Announce Second Quarter 2024 Financial Results on Friday, August 2, 2024Press release+0.76%-0.10%
Form 10-Q Fulgent Genetics, Inc. For: Mar 31SEC filing · Form 10-Q+1.17%+4.88%
Fulgent Reports First Quarter 2024 Financial ResultsPress release+1.17%+4.88%
Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024Press release+0.29%-1.09%
Form 10-K Fulgent Genetics, Inc. For: Dec 31SEC filing · Form 10-K+2.54%-3.55%
Form 10-Q Fulgent Genetics, Inc. For: Sep 30SEC filing · Form 10-Q+4.45%+10.59%
Fulgent Reports Third Quarter 2023 Financial ResultsPress release+4.45%+10.59%
Fulgent Genetics to Announce Third Quarter 2023 Financial Results on Friday November 3, 2023Press release+1.52%+0.36%
That’s how FLGT usually reacts to earnings — get an email when it moves on news →
Keep exploring

More FLGT: analyst actions → · SEC filings → · FLGT overview →

Other Healthcare names and their earnings

TickerEventsMedian 30-min% positive
Neuronetics, Inc. (STIM)395-0.21%45%
Axogen, Inc. (AXGN)393-0.12%48%
Kazia Therapeutics Limited - American Depositary Shares (KZIA)393-1.07%34%
OHR PHARMACEUTICALS (OHRP)3930.00%48%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.